Savara (SVRA) Change in Accrued Expenses (2009 - 2026)
Savara's Change in Accrued Expenses came in at $1.48 million for Q2 2026, up 24.4% from $1.19 million a year earlier.
Powered by 
Analysis
Savara (SVRA) Change in Accrued Expenses (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Savara reported Change in Accrued Expenses of $3.61 million, up 115.2% year-over-year; for FY2025, it was $4.81 million, up 14.4% from FY2024.
- Going back by year, Change in Accrued Expenses was $4.2 million in FY2024 (-7.5%), $4.54 million in FY2023, -$319,000 in FY2022 and -$1.76 million in FY2021.
- The five-year range for quarterly Change in Accrued Expenses is -$4.64 million (Q1 2026) to $3.65 million (Q4 2025).
- Year-over-year, Change in Accrued Expenses increased in four of the last six quarters, with growth averaging 33.4%.
- The fastest year-over-year change in Change in Accrued Expenses over five years came in Q4 2023 (growth of 230.3%), and the weakest in Q3 2024 (a decline of 55.1%).
- Business Quant data shows SVRA's Change in Accrued Expenses at -$4.64 million (Q1 2026), $3.65 million (Q4 2025) and $3.12 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Savara | 1.09 Bn | 407.27 Mn | - | -99,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -99,000.00 |
| Jun 30, 2026 | 1.48 Mn |
| Mar 31, 2026 | -4.64 Mn |
| Dec 31, 2025 | 3.65 Mn |
| Sep 30, 2025 | 3.12 Mn |
| Jun 30, 2025 | 1.19 Mn |
| Mar 31, 2025 | -3.15 Mn |
| Dec 31, 2024 | 2.26 Mn |
| Sep 30, 2024 | 1.38 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | -770,000.00 |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 3.06 Mn |
| Jun 30, 2023 | 988,000.00 |
| Mar 31, 2023 | -976,000.00 |
| Dec 31, 2022 | 445,000.00 |
| Sep 30, 2022 | 1.70 Mn |
| Jun 30, 2022 | 16,000.00 |
| Mar 31, 2022 | -2.48 Mn |
| Dec 31, 2021 | -278,000.00 |
API Access
Savara Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=SVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "SVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=SVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();